Wenzhou Central Hospital
Wenzhou, Zhejiang, China
NCT Number: NCT07047937
Abstract Background: Early detection of gastric cancer is crucial for improving patient survival rates. Currently, the primary method for diagnosing early-stage gastric cancer is endoscopy, which has various limitations. Additionally, single laboratory tests continue to fall short of the requirements for early screening. This study aims to develop a machine learning (ML) model using clinical data to predict early-stage gastric cancer and apply SHapley Additive exPlanation (SHAP) values to explain the ML model.
Methods: This study involved patients who provided gastric tissue samples at Wenzhou Central Hospital from 2019 to 2023. The investigators gathered various laboratory test results from these patients. The investigators constructed and evaluated nine ML models to predict early-stage gastric cancer, using the area under the curve (AUC), accuracy, and sensitivity to assess their performance. For the most effective prediction model, The investigators utilized the SHAP method to determine the features' importance and explain the ML model.
Interested in participating?
Request InfoAll sexes
Observational
Wenzhou, Zhejiang, China
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From June 2025 to July 2025
The area under the ROC curve (AUC) was used as the primary outcome measure
Time frame: From June 2025 to July 2025
We considered the sensitivity of the model as a secondary outcome measure.
Time frame: From June 2025 to July 2025
We included model accuracy as other outcome measures.
Wenzhou Central Hospital
Other
Explainable Machine Learning for Predicting Early Gastric Cancer: a Retrospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07724496
Digestive System Diseases, Digestive System Neoplasms
Beijing, Beijing Municipality, China
View Trial DetailsNCT07486518
Digestive System Diseases, Digestive System Neoplasms
Hyderabad, Telangana, India
View Trial DetailsNCT07615374
Digestive System Diseases, Digestive System Neoplasms
Ch’ang-ch’un, Jilin, China
View Trial DetailsNCT06788548
Digestive System Diseases, Digestive System Neoplasms
Beijing, Beijing Municipality, China
View Trial Details